Facebook
Twitter
Telegram
Report an ErrorSeres Therapeutics Financial Statements 2011-2024 | MCRB
Annual Financial Statements Seres Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
137 M | 568 M | 734 M | 1.52 B | 189 M | 250 M | 421 M | 375 M | 634 M | - | - | - | - |
Shares |
128 M | 108 M | 91.7 M | 79.8 M | 56.6 M | 40.7 M | 40.4 M | 39.8 M | 23.5 M | - | - | - | - |
Historical Prices |
1.07 | 5.26 | 8 | 19 | 3.14 | 6.13 | 9.5 | 9.68 | 23.1 | - | - | - | - |
Net Income |
-114 M | -250 M | -65.6 M | -89.1 M | -70.3 M | -98.9 M | -89.4 M | -91.6 M | -54.8 M | -16.7 M | -6.1 M | -3.13 M | - |
Revenue |
126 M | 7.13 M | 145 M | 33.2 M | 34.5 M | 28.3 M | 32.1 M | 21.8 M | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-108 M | -246 M | -64.5 M | -88.1 M | -71.9 M | -100 M | -91.4 M | -92.8 M | -54.9 M | -15.1 M | -6.05 M | - | - |
Interest Expense |
134 K | -705 K | -1.04 M | 981 K | 1.07 M | - | 1.59 M | 1.26 M | 83 K | - | - | - | - |
EBITDA |
-102 M | -240 M | -58.5 M | -81.6 M | -62.8 M | -92.4 M | -84.1 M | -88.6 M | -54.1 M | -13.5 M | -5.96 M | -3.01 M | - |
Operating Expenses |
234 M | 254 M | 209 M | 121 M | 105 M | 129 M | 123 M | 115 M | 54.9 M | - | - | - | - |
General and Administrative Expenses |
87.7 M | 79.7 M | 69.3 M | 30.8 M | 24.7 M | 32.6 M | 34 M | 32.6 M | 16.8 M | 4.36 M | 1.25 M | 956 K | - |
All numbers in USD currency
Quarterly Income Statement Seres Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
146 M | 135 M | 128 M | 128 M | 126 M | 125 M | 123 M | 92.3 M | 92.2 M | 91.9 M | 91.8 M | 91.7 M | 91.5 M | 91.5 M | 83.5 M | 73.3 M | 70.8 M | 70.1 M | 69.9 M | 45.1 M | 41 M | 40.9 M | 40.8 M | 40.7 M | 40.6 M | 40.6 M | 40.5 M | 40.4 M | 40.4 M | 40.4 M | 40.2 M | 39.6 M | 39.2 M | 39.1 M | 39 M | 8.64 M | 8.64 M | 6.89 M | 6.77 M | 6.73 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-40.1 M | - | -47.9 M | 46.6 M | -71.2 M | - | -60 M | -64.7 M | -56.6 M | - | 68.2 M | -48.3 M | -35.5 M | - | -30.3 M | -20.7 M | -19.9 M | -18.8 M | -16.4 M | -10.8 M | -24.3 M | -21.3 M | -21.9 M | -27.8 M | -27.9 M | -29 M | -6.94 M | -28 M | -25.5 M | -25.3 M | -18.7 M | -27.9 M | -19.7 M | -19.6 M | -14.6 M | -12.6 M | -7.97 M | -8.18 M | -4.16 M | -2.68 M | -1.69 M | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | 310 K | 126 M | -522 K | - | 3.44 M | 1.22 M | 1.49 M | - | 127 M | 5.26 M | 5.72 M | - | 1.42 M | 6.04 M | 8.19 M | - | 7.03 M | 12.5 M | 7.32 M | - | 9.06 M | 4.61 M | 3.97 M | 3.06 M | 23 M | 3.01 M | 3.02 M | 3.04 M | 13 M | 3 M | 2.71 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-39.6 M | - | -47.4 M | 49.5 M | -70.6 M | - | -59.1 M | -63.3 M | -55.8 M | - | 68.4 M | -48.1 M | -35.3 M | - | -30 M | -20.5 M | -19.7 M | -19.2 M | -17.2 M | -10.9 M | -24.6 M | -21.7 M | -22.2 M | -28.1 M | -28.3 M | -29.8 M | -7.31 M | -28.4 M | -25.9 M | -25.7 M | -19.1 M | -28.1 M | -19.9 M | -19.8 M | -14.6 M | -12.3 M | -8.17 M | -7.21 M | -3.58 M | -2.62 M | -1.67 M | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
2.47 M | - | 999 K | -1.51 M | 310 K | - | -33 K | -304 K | -345 K | - | -35 K | -285 K | -409 K | - | 345 K | 476 K | 368 K | - | - | - | - | - | 262 K | - | 347 K | - | -123 K | -217 K | -359 K | - | -312 K | -268 K | -56 K | - | -59 K | 5 K | - | - | -61 K | -56 K | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-38 M | - | -45.7 M | 51.1 M | -69.2 M | - | -57.4 M | -61.6 M | -54.2 M | - | 69.9 M | -46.7 M | -33.8 M | - | -28.4 M | -18.9 M | -17.9 M | -19.2 M | -15.3 M | -9.03 M | -22.5 M | -21.7 M | -20.2 M | -26.2 M | -26.3 M | -29.8 M | -5.45 M | -26.7 M | -24.2 M | -25.7 M | -17.8 M | -27.3 M | -19.5 M | -19.8 M | -14.4 M | -12.2 M | -8.08 M | -7.21 M | -3.53 M | -2.58 M | -1.67 M | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
39.6 M | - | 47.7 M | 76.9 M | 70 M | - | 62.6 M | 64.5 M | 57.2 M | - | 58.3 M | 53.4 M | 41 M | - | 31.4 M | 26.6 M | 27.9 M | 26.8 M | 24.2 M | 23.5 M | 31.9 M | 32.3 M | 31.3 M | 32.7 M | 32.2 M | 32.8 M | 30.3 M | 31.4 M | 28.9 M | 28.7 M | 32.1 M | 31.1 M | 22.6 M | 19.8 M | 14.6 M | 12.3 M | 8.17 M | 7.21 M | 3.58 M | 2.62 M | 1.67 M | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
15.5 M | - | 20 M | 28.1 M | 22.5 M | - | 18.4 M | 20.3 M | 18.6 M | - | 19.6 M | 17.5 M | 11.7 M | - | 7.55 M | 6.49 M | 6.14 M | - | 5.9 M | 5.57 M | 7.5 M | - | 7.59 M | 8.7 M | 8.78 M | - | 8.12 M | 8.37 M | 8.76 M | - | 7.97 M | 8.97 M | 7.21 M | - | 4.71 M | 3.56 M | 3.56 M | - | 1.11 M | 458 K | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency